SEARCH

SEARCH BY CITATION

References

  • Association of British Pharmaceutical I. ABPI Compendium of Data Sheets and Summaries of Product Characteristics, 1999-2000: With the Code of Practice for the Pharmaceutical Industry. London: Datapharm Publications; 1999.
  • Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ, Willey-Courand DB, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007; 176: 957969.
  • Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, et al. Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155(6 Suppl): S73S93.
  • Heijerman H, Westerman E, Conway S, Touw D, Doring G. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus. J Cyst Fibros 2009; 8: 295315. Epub June 30, 2009.
  • Balfour-Lynn IM, Welch K. Inhaled corticosteroids for cystic fibrosis. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD001915. DOI: 10.1002/14651858.CD001915.pub3